北美抗生素市场预测至 2027 年 - Covid-19 影响和按药物类别(磺胺类、氨基糖苷类、碳青霉烯类、大环内酯类、氟喹诺酮类、青霉素、头孢菌素等)的区域分析;作用机制(霉菌酸抑制剂、RNA合成抑制剂、DNA合成抑制剂、蛋白质合成抑制剂、细胞壁合成抑制剂);和国家

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 117    |    Report Code: TIPRE00011569    |    Category: Life Sciences

North America Antibiotics Market

市场介绍

抗生素是一组对抗细菌感染(有时也对抗原虫疾病)的药物。此外,它们还用于治疗许多疾病,如链球菌性咽喉炎、尿路感染、鼻窦感染、肺炎、眼部和呼吸道感染。耳部感染等。抗生素也称为抗微生物剂或抗菌剂。 1920 年发现抗生素青霉素后,各种其他抗生素化合物已被用于治疗多种细菌感染。

市场概况和动态

< /span>

北美抗生素市场预计将从 2019 年的 135.2779 亿美元增至 2027 年的 180.0425 亿美元。预计从 2020 年开始,该市场将以 3.9% 的复合年增长率增长到2027年。推动市场增长的因素是传染病的流行和仿制药的不断发展。然而,繁琐且昂贵的抗生素开发过程以及 COVID-19 大流行的影响可能会对市场增长产生负面影响。

关键细分市场< /strong>

按药物类别来看,2019年北美抗生素市场中头孢菌素类药物占据最大市场份额。从作用机制来看,细胞壁合成抑制剂类药物为预计到 2027 年将占据抗生素市场最大的市场份额。

主要来源和上市公司

报告中包含的抗生素市场的一些主要主要和次要来源包括世界卫生组织(WHO)、食品和药物管理局(FDA)、美国微生物学会(ASM)、疾病控制和预防中心(CDC) ,疾病动态、经济与研究中心政策 (CDDEP) 等。

购买报告的理由

  • 了解抗生素市场格局并确定最有可能保证丰厚回报的细分市场
  • 保持领先地位了解抗生素市场不断变化的竞争格局
  • 通过识别最有可能销售前景的细分市场,有效规划抗生素市场的并购和合作交易
  • 通过对抗生素市场各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策
  • 获得市场的市场收入预测2019 年至 2027 年北美地区各个细分市场。

北美抗生素市场细分

按药物类别

  • 头孢菌素
  • 青霉素
  • 氟喹诺酮类
  • 大环内酯类
  • 碳青霉烯类
  • 氨基糖苷类
  • 磺胺类药物
  • 其他
< p>

 

按动作机制

    < li>细胞壁合成抑制剂
  • 蛋白质合成抑制剂
  • DNA合成抑制剂
  • RNA合成抑制剂
  • 霉菌酸抑制剂
  • 其他

按地理位置

  • 北美洲
  • < span>美国
  • 加拿大
  • 墨西哥

公司简介

  • 强生公司约翰逊服务公司
  • 百时美施贵宝公司
  • 礼来公司。
  • 雅培
  • 辉瑞公司


North America Antibiotics Strategic Insights

Strategic insights for North America Antibiotics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-antibiotics-market-strategic-framework.webp
Get more information on this report

North America Antibiotics Report Scope

Report Attribute Details
Market size in 2019 US$ 13,527.79 Million
Market Size by 2027 US$ 18,004.25 Million
Global CAGR (2020 - 2027) 3.9%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 药物类别
  • 磺胺类
  • 氨基糖苷类
  • 卡巴培南类
  • 大环内酯类
  • 氟喹诺酮类
  • 青霉素类
  • 头孢菌素类
By 作用机理
  • 肌酸抑制剂
  • RNA合成抑制剂
  • DNA合成抑制剂
  • 蛋白质合成抑制剂
  • 细胞壁合成抑制剂
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Johnson & Johnson Services, Inc
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company.
  • Abbott
  • Pfizer Inc
  • Get more information on this report

    North America Antibiotics Regional Insights

    The regional scope of North America Antibiotics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-antibiotics-market-geography.webp
    Get more information on this report

    The List of Companies - North America Antibiotics Market

    The List of Companies - North America Antibiotics Market

    1. Johnson & Johnson Services, Inc
    2. Bristol-Myers Squibb Company
    3. Eli Lilly and Company.
    4. Abbott
    5. Pfizer Inc
    Frequently Asked Questions
    How big is the North America Antibiotics Market?

    The North America Antibiotics Market is valued at US$ 13,527.79 Million in 2019, it is projected to reach US$ 18,004.25 Million by 2027.

    What is the CAGR for North America Antibiotics Market by (2020 - 2027)?

    As per our report North America Antibiotics Market, the market size is valued at US$ 13,527.79 Million in 2019, projecting it to reach US$ 18,004.25 Million by 2027. This translates to a CAGR of approximately 3.9% during the forecast period.

    What segments are covered in this report?

    The North America Antibiotics Market report typically cover these key segments-

  • 药物类别 (磺胺类, 氨基糖苷类, 卡巴培南类, 大环内酯类, 氟喹诺酮类, 青霉素类, 头孢菌素类)
  • 作用机理 (肌酸抑制剂, RNA合成抑制剂, DNA合成抑制剂, 蛋白质合成抑制剂, 细胞壁合成抑制剂)
  • What is the historic period, base year, and forecast period taken for North America Antibiotics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Antibiotics Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in North America Antibiotics Market?

    The North America Antibiotics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Johnson & Johnson Services, Inc
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company.
  • Abbott
  • Pfizer Inc
  • Who should buy this report?

    The North America Antibiotics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Antibiotics Market value chain can benefit from the information contained in a comprehensive market report.